Chromosomal aberrations with breakpoints in T-cell receptor (TCR) gene loci are recurrent in several T-cell malignancies. Although the importance of interphase cytogenetics has been extensively shown in B-cell lymphomas, hardly any molecular cytogenetic tools are available for recurrent changes in T-cell disorders. Thus, we have established fluorescence in situ hybridization (FISH)-based break-apart assays for the TCRA/D (14q11), TCRB (7q34) and TCRG (7p14) genes and the TCL cluster (14q32). The assays were validated in normal controls as well as in 43 T-cell malignancies with cytogenetically proven 14q11, 7q34-35 or 7p13-21 aberrations. Breakpoints in TCRA/D, TCRB and TCRG could be diagnosed by these assays in 32/33 T-cell neoplasms with chromosome 14q11, 3/6 with 7q34-35 and 1/7 with 7p13-21 alterations, respectively. Application of the new FISH assays to a series of 24 angioimmunoblastic and 12 cutaneous T-cell lymphomas confirmed the cytogenetic evidence of lack of breakpoints in the TCRA/D or TCRB locus. Simultaneous detection of TCRA/D or TCRB breaks was achieved in a multicolor approach, which was further combined with detection of the T-cell-specific CD3 antigen in a multicolor FICTION (Fluorescence Immunophenotyping and Interphase Cytogenetics as a Tool for the Investigation of Neoplasm) assay. These new FISH and FICTION assays provide sensitive, rapid and accurate tools for the diagnosis and biological characterization of T-cell malignancies.
Introduction
Precursor and mature T-cell malignancies account for around 10-15% of all lymphoid neoplasms in Western countries. 1, 2 The genetic background of these malignancies seems to be heterogeneous and is, with few exceptions, widely unknown. 2 Nevertheless, in analogy with breakpoints in immunoglobulin (IG) loci, which are present in the majority of B-cell disorders, 3, 4 a common cytogenetic feature of some T-cell disorders is the presence of chromosomal aberrations with breakpoints in one of the T-cell receptor (TCR) loci. [5] [6] [7] [8] So far, various chromosomal changes with breakpoints involving either the TCRA/D gene located at chromosomal band 14q11 or TCRB located at 7q34 have been described. To the best of our knowledge, molecularly confirmed translocations involving TCRG (7p14) have not been reported so far. The chromosomal alterations juxtapose oncogenes next to TCR regulatory sequences leading to deregulated expression of those oncogenes. 9, 10 From such translocations affecting TCRA/D and/or TCRB, a number of different oncogenes have been cloned, which are located at chromosomal bands 1p32 (TAL1/SCL), 1p34 (LCK), 8q24 (MYC), 9q34 (TAL2), 9q34.3 (TAN1/NOTCH1), 10q24 (HOX11), 11p13 (RBTN2/ TTG2/LMO2), 11p15 (RBTN1/TTG1/LMO1), 14q32 (TCL1A, TCL1B, TCL6/TNG), 19p13 (LYL1), 21q22 (BHLHB1) and Xq28 (C6.1B). 10, [11] [12] [13] Among those chromosomal changes, the inv(14)(q11q32) and t(14;14)(q11;q32) involving the TCL gene cluster, and the t(X;14)(q28;q11) involving the C6.1B gene, are commonly associated with the diagnosis of T-cell prolymphocytic leukemia (T-PLL). 5, 11, 12, 14, 15 The other TCR translocations appear predominantly in precursor T-cell lymphoblastic leukemia/lymphoma (T-LBLL), but each with a low incidence. 1, 7 In contrast to T-PLL and T-LBLL, structural chromosomal aberrations involving 14q11, 7q34-35 and 7p13-21 seem to be rare in other subtypes of T-cell lymphoma relying on conventional cytogenetic data. [16] [17] [18] [19] The routine detection of illegitimate rearrangements of the TCR loci demands a robust, accurate and rapid method. Nowadays, a reliable approach to detect chromosomal breakpoints in a gene regardless of its partner chromosome is a fluorescence in situ hybridization (FISH) assay containing two differentially labeled probes flanking the locus. [20] [21] [22] In direct contrast to T-cell disorders, such FISH approaches have been extensively applied to B-cell malignancies, where they meanwhile constitute important diagnostic and research tools. [23] [24] [25] In order to facilitate the genetic analyses of T-cell disorders, we have developed and validated a new set of FISH probes flanking the TCR loci as well as the TCL gene cluster. We show the applicability of this probe set for multicolor interphase cytogenetics, including combination with staining for the CD3 antigen (T-lineage specific) by means of the Fluorescence Immunophenotyping and Interphase Cytogenetics as a Tool for the Investigation Of Neoplasms (FICTION) technique. 26, 27 Applying the novel assays to cutaneous and angioimmunoblastic-type mature T-cell neoplasms, we show breakpoints of the TCRA/D and TCRB to be absent -or at least infrequent -in these lymphoma subtypes.
Materials and methods

Patients and controls
Tumor samples from lymph node, bone marrow, peripheral blood or pleural fluid from a total of 43 T-cell malignancies with 46 cytogenetically proven breakpoints at 14q11, 7q34-35 or 7p13-21 were analyzed in the present study. Partial karyotypes and patient data are given in Figures 1-3 . Additionally, 24 angioimmunoblastic T-cell lymphomas (AITL), six Sezary syndromes (SS), six mucosis fungoides (MF) and three peripheral T-cell lymphomas (PTCL) without cytogenetic evidence fortumor cytogenetic analysis were used for FISH, whereas frozen cytospins were utilized for FICTION studies. Peripheral blood mononuclear cells from healthy donors with normal karyotypes served as negative controls.
Clone selection
Bioinformatic resources available at NCBI (http://www.ncbi. nlm.nih.gov), Washington University (http://genome.wustl.edu) and University of California at Santa Cruz (http://genome.ucsc. edu) were utilized to select appropriate clones. Table 1 shows the clones for the TCRA/D, TCRB, TCRG and TCL loci applied in the present study. As the TCL-associated breakpoints segregate into two regions, 12, 15 the TCL flanking probe was designed to detect both breakpoint regions.
Probe preparation and FISH
BAC clones were grown overnight in LB media supplemented with chloramphenicol. DNA was prepared using the Perfectprep Plasmid Maxi Kit (Eppendorf, Kö ln, Germany). Clones flanking the TCRA/D, TCRB, TCRG and TCL loci were labeled differentially with dUTP-spectrum orange (SO, Vysis, Downers Groove, USA) and dUTP-spectrum green (SG, Vysis) by random priming (Bioprime, Life Technologies, Karlsruhe, Germany) exchanging the dNTP-Bio with the appropriate dNTP mixture. For the multicolor assay, dUTP-Cy5 (Amersham Pharmacia Biotech, UK) and dUTP-DEAC (NEN, Zaventem, Belgium) were used in addition to SO and SG to label probes. Labeled products were purified with Sephadex G-50 columns. 200 ng of each probe were coprecipitated with 5 ml of Cot1-DNA (Life Technologies, Karlsruhe, Germany) and resuspended in 10 ml of master mix containing 2 Â SSC, 50% formamide and 10% dextran sulfate. Additional FISH probes used to confirm the involvement of TCR loci partner genes were REL (2p13), LSI MYC (8q24; Vysis, Downers Grove, USA), NOTCH1 (9q34, BACs RP11-251M1 telomeric and RP11-83N9 centromeric), HOX11 (10q24) and BCL11B (14q32, CTD-3104H21 centromeric and CTD-2200A16 telomeric) [29] [30] [31] [32] (own unpublished data). FISH was performed as described recently 21 using either the dual-color or multicolor probe sets. Slides were counterstained with DAPI and mounted in antifade solution. For dualcolor experiments, hybridization signals were analyzed by use of a Zeiss Axioskop 2 fluorescence microscope (Zeiss, Gö ttingen, Germany) with suitable filter sets (AHF, Tü bingen, Germany) and documented using ISIS imaging system (MetaSystems, Altlussheim, Germany). Cytogenetic location and signal intensity of the BAC clones was tested on normal metaphases and interphase nuclei.
Determination of cutoff levels for false-positive findings
For the determination of the diagnostic thresholds of the new probe sets, 200 nuclei were evaluated in each five negative controls. By using flanking probes, two colocalizations of each signal for the centromeric and telomeric probes are expected in healthy donors. However, as the genomic distance between centromeric and telomeric probes is several hundred kb, flanking signals might appear slightly separated in cells lacking a chromosomal breakpoint. Thus, in order to define precisely a 'split', the distance between the differently colored signals of a signal pair within the nucleus was estimated in relation to the signal diameter by visual inspection. 21 The diagnostic cutoffs were calculated as the mean of false positives in controls plus three times the standard deviation (s.d.). 33 
Multicolor FICTION
A monoclonal antibody (MoAb) anti-CD3 (T-cell specific) was combined with the multicolor probe set for the detection of breakpoints in the TCRA/D and TCRB loci. Cytospin slides were thawed and dried for 30 min at room temperature (RT), fixed in acetone for 10 min and air-dried. Slides were incubated for 30 min at RT with a primary MoAb anti-CD3 (1:50) (DAKO, Hamburg, Germany) diluted in PNM buffer. Fluorescence detection was performed with a sequential cascade of three AMCA-conjugated Abs diluted in PNM buffer (1:20) for 30 min each at RT: (1) AMCA-conjugated rabbit anti-mouse, (2) AMCAconjugated goat anti-rabbit and (3) AMCA-conjugated donkey anti-goat (all from Jackson Immunoresearch/Dianova, Hamburg, Germany). After immunophenotyping, slides were fixed in Carnoy's fixative (methanol:acetic acid, 3:1) for 10 min and in paraformaldehyde solution (1%) for 1 min. Then slides were dehydrated through increasing ethanol concentrations (70%, 85% and absolute) and air-dried. The multicolor probe pool (1.5 ml) was applied to the cytospin imprint and covered with a round 10 mm coverslip. Both probe and target DNA were simultaneously denatured at 701C for 12 min and incubated overnight at 371C. Posthybridization washes were performed in 0.1 Â SSC three times for 5 min each at 601C. Then, slides were washed once in PN buffer and then mounted in antifade solution. For multicolor experiments, images were acquired and processed using a motorized epifluorescence microscope (Axioplan 2 imaging mot, Zeiss) equipped with narrow bandpass filters and MetaSystems isis/mFISH imaging system. 27 
Results
Negative control studies
After hybridization on normal metaphases, all probes shown in Table 1 mapped to the correct chromosomal location and gave two intense hybridization signals in interphase nuclei. Based on Table 1 Clones flanking the TCRA/D, TCRB, TCRG and TCL loci selected for the present study
RPCI11-725G5 Centromeric RPCI11-164H13 Telomeric to centromeric breakpoint cluster/spanning the telomeric breakpoint cluster RPCI11-185P18 RPCI: Roswell Park Cancer Institute.
Detection of TCR breakpoints by molecular cytogenetics S Gesk et al the results in negative controls, a 'split' was defined for each TCRA/D and TCRB assay as a spatial separation of the flanking probes of more than three times the estimated signal diameter. For the assays flanking the TCRG locus and the TCL gene cluster, a separation of twice the estimated signal diameter was considered. Using these criteria, the cutoff levels were 5.7% for TCRA/D, 5.5% for TCRB, 1.6% for TCRG and 4.1% for TCL.
Double-color interphase FISH in T-cell malignancies
To prove the diagnostic validity of the newly established FISH assays, 43 T-cell malignancies with a total of 46 breakpoints affecting 14q11, 7q34-35 and 7p13-21 were studied. In addition to classical signal splits, variant hybridization patterns including loss or gain of isolated telomeric or centromeric signals because of loss or gain of derivative chromosomes, respectively, were considered as indicative for a chromosomal breakpoint.
Translocations/inversion affecting 14q11: In all, 31 of the 33 T-cell malignancies with 14q breaks displayed a signal constellation indicating a breakpoint in the TCRA/D locus in at least 15% of the cells (average: 46%, range: 15-89%). In all these cases, the percentage of aberrant nuclei exceeded the cutoff level of 5.7%. A bone marrow sample from case no. 13, with a t(10;14) in 3/28 metaphases by conventional cytogenetic analysis, contained only 4% of cells with a signal split, which is below the cutoff for this assay. Nevertheless, one metaphase was observed in this case showing a disruption of the TCRA/D signal and translocation of the distal signal to the der(10)t (10;14) . In cases with 8q24, 9q34 and 10q24 breaks, involvement of MYC, TAN1/NOTCH1 and HOX11, respectively, was demonstrated by FISH. The application of probes for the REL and BCL11B/ CTIP2 loci suggested involvement of these genes in cases 4 and 18, respectively (Figure 1 ).
Translocations affecting 7q34-35: Three out of the six cases with structural aberrations in 7q34-35 displayed aberrant signal constellations in 61-74% of the cells, indicating the presence of a breakpoint in TCRB. The translocation partners were 10q24 in case nos. 37 and 38, and 11p13 in case no. 39 ( Figure 2 T-PLL  TCL  T-PLL  TCL  T-LBLL  T-LBLL  T-PLL  TCL   16  6  21  48  17  3  24  54  8  6  10  6  48  20  4  62  2  41  66  62  69  70  71  47  51  71  56  32  77  16  4 Inversion inv(14)(q11q32): In nine cases with inv (14) (q11q32) (nos. [19] [20] [21] [22] [23] [24] [25] [26] [27] , signal constellations indicating breakpoints in the TCL gene cluster were observed in 12-73% of the nuclei (Figures 4 and 5b) . Case no. 22 showed a split within the TCL telomeric probe, whereas in the remaining eight cases a classical split between centromeric and telomeric probes was observed. These patterns suggest that the telomeric breakpoint region is most likely involved in the first case and the centromeric breakpoint region in the others. There was a good agreement between the results obtained by this assay and those gathered by the TCRA/D assay. The ATLL case (no. 18) with a t(14;14) did not shown a breakpoint in the TCL cluster. Further studies revealed a break event in the BCL11B locus in 14q32 in this case.
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Multicolor interphase FISH (MI-FISH):
Based on the double-color FISH patterns, five cases (nos. 1, 7, 14, 17 and 37) were selected to test the performance of an MI-FISH assay aiming to detect simultaneously breakpoints in the TCRA/D and TCRB loci in a single hybridization experiment. These cases were studied with the multicolor approach and the breakpoints in TCRA/D (cases 1, 7, 14 and 17) and TCRB (case 37, Figure 5d ) were confirmed. Surprisingly, in case 17, which bears a cytogenetically proven t(12;14)(q23Bq24;q11) translocation, a breakpoint in the TCRB locus was observed concurrently with the known TCRA/D involvement. Subsequent double-color FISH Figure 2 FISH analysis for breakpoints in the TCRB locus in cases with cytogenetically proven 7q34-35 break. *Partner gene involvement proven by FISH. **A break involving TCRB was revealed by interphase cytogenetics although no cytogenetically proven 7q34-35 alteration was observed. The vertical dotted line indicates the cutoff level of 5.5%. T-PLL: T-cell prolymphocytic leukemia; SS: Sezary syndrome; T-LBLL: precursor T-cell lymphoblastic leukemia/lymphoma; TCL: T-cell lymphoma, unspecified; m: male; f: female. t(1;7)(p31~32;p1?3) t(3;7)(p21;p15) t(6;7)(q13;p13),t(6;7)(p21;p13) del(7)(p11p21) del (7) (Figure 5e ). In case 17, the simultaneous presence of breakpoints in TCRA/D and TCRB was confirmed and found to be confined to the CD3-positive cell population (Figure 5g ).
FISH in AITL, SS, MF and PTCL without cytogenetic involvement of chromosomes 7 or 14
Cryptic rearrangements hidden in either seemingly normal or complex karyotypes can be frequently found in certain B-cell disorders, for example, multiple myeloma. 34 Therefore, we Figure 5 (a) Metaphase of case no. 30 with a t(1;7)(q31B32;p1?3) hybridized with the TCRG flanking probe. A fusion of red and green signals points to the intact TCRG locus, whereas the signal split indicates the presence of a translocation affecting TCRG, in which the red (centromeric) and green (telomeric) signals are located on the der(7) (arrow) and der(1) (arrowhead) derivative chromosomes, respectively. (b) Metaphase and interphase nucleus from case number 26 with an inv(14)(q11q32) hybridized with the TCL flanking probe. Both the metaphase and the interphase nucleus display an intact and a rearranged TCL gene cluster. As a result of the inv(14) (arrow), the centromeric signal (green) moves to 14q11, whereas the telomeric signal (red) remains on 14q32. Detection of TCR breakpoints by molecular cytogenetics S Gesk et al studied 24 AITL, six SS, six MF and three PTCL without any cytogenetic breaks in 14q11 and 7q34-35 with the TCRA/D (all 39 cases) and TCRB (37 cases) flanking assays. One SS and one MF were not studied with the TCRB flanking probe because of scarcity of material. All T-cell lymphomas included in this series displayed hybridization patterns indicating absence of TCRA/D and TCRB translocation events (data not shown).
Discussion
According to the novel WHO classification of hematological malignancies, recurrent genetic aberrations constitute diagnostic markers for the histopathologic and prognostic classification of these diseases. 35 However, in comparison with myeloid or Bcell malignancies, T-cell disorders are cytogenetically poorly characterized. Thus, the number of genetic markers for their differential diagnosis and prognosis is rather limited. One of the few exceptions is anaplastic large cell lymphoma, which is associated with the t(2;5)(p23;q35) and variant translocations affecting the ALK gene at 2p23. 36, 37 Like IG chromosomal translocations in their B-cell counterparts, 3, 4 some T-cell malignancies bear illegitimate chromosomal rearrangements affecting the TCR loci TCRA/D in 14q11 and TCRB in 7q34, which appear to be derived from errors of the RAG-mediated V(D)J recombination process. 10, 38 In contrast, translocations affecting the TCRG locus have not yet been reported to our knowledge.
Nowadays, a robust method to detect rearrangements of a promiscuous locus regardless of its translocation partner is an interphase FISH assay with differentially labeled probes flanking the recurrent breakpoint. [20] [21] [22] 29 For TCRA/D, a FISH assay using a single YAC clone spanning this locus has been previously reported, 39 but its application to interphase nuclei is not optimal. For instance, duplications of 14q11 or trisomies 14 would give a hybridization pattern similar to that derived from a split of the YAC clone and can, thus, produce false-positive results. On the contrary, a simultaneous breakpoint in TCRA/D and loss of one derivative chromosome would be scored as normal, since only two signals would appear. Consequently, we have designed novel FISH assay for the detection of translocations affecting all TCR loci.
The TCRA/D and TCRB loci have a genomic size of about 1 and 0.7 Mb, 40, 41 respectively. Therefore, the differentially labeled probes flanking these huge loci have to be necessarily far away from each other. Considering this fact, we took the distance between the signals on intact loci into account for the evaluation process. Based on our extensive control studies, the cutoff levels were 5.7% for the TCRA/D and 5.5% for the TCRB FISH assay when the distance between flanking probes was more than three times the estimated signal diameter. For TCRG, which covers approximately 160 kb, the flanking probes could be closer to each other. Consequently, the cutoff was 1.6% when the distance between probes was more than only twice the signal diameter. For the TCL gene cluster, two breakpoint regions have been described on both sides of the cluster 11, 12, 15 with the telomeric breakpoint region commonly associated with t(14;14) and t (7;14) . Remarkably, a signal constellation suggesting involvement of the telomeric breakpoint region was detected in one of the nine cases with inv(14) studied herein.
FISH for TCR loci was applied to a total of 43 T-cell malignancies with cytogenetically proven alterations affecting 14q11, 7q34-35 or 7p13-21. In all cases with chromosomal alterations previously described to contain oncogenes juxtaposed to TCR loci, the breakpoints were confirmed to involve TCR genes. One case was found to contain a TCRG breakpoint as a result of a t(1;7)(p31-32;p13), which probably involves the TAL1 or LCK oncogene. To the best of our knowledge, this is the first time that direct evidence for a translocation affecting the TCRG locus is provided. In all AITL, SS, MF and PTCL cases without cytogenetic implication of TCR-associated chromosomal bands, cryptic breaks affecting TCRA/D or TCRB were ruled out. This finding indicates that oncogene activation via TCR translocations plays, if at all, a minor role in these T-cell malignancies.
Our study also points to new candidate oncogenes targeted by TCR translocations that are located at 2p16, 11q23, 12q23-24, 14q32, 18p11 and 20p12. Among these regions, we attempted to identify the partner genes at 2p16 (case no. 4) and 14q32 (case no. 18). The 2p16 break was found in a patient with PTCL. Interestingly, split of the probe targeting the REL locus in 2p13-16 was found. REL is a member of the Rel/NF-kB family of transcription factors that has been repeatedly described as amplified or (less frequently) translocated in B-cell malignancies and classical Hodgkin's lymphoma. 31, 42, 43 Nevertheless, we here describe for the first time a breakpoint within or close to the REL locus in a T-cell disorder. The 14q32 break was found in a patient with sporadic ATLL (already published by Reinhardt et al 28 ). Breakpoints in 14q11 and 14q32, as well as genomic amplifications of 14q32, are recurrent in ATLL. 44, 45 However, not all cases with 14q11 breaks appear to involve TRCA/D. Moreover, the breaks in 14q32 in ATLL seem not to target TCL1. 46 They have been reported to map mostly between TCL1 and the telomeric marker D14S250 although no candidate oncogenes in ATLL have been described so far. 47 A gene located in that region is BCL11B/CTIP2. This gene encodes for a transcriptional repressor involved in a T-ALL-associated t(5;14)(q35;q32) translocation. 30, 48 BCL11B/CTIP2 is the homologue of BCL11A/CTIP1, which is juxtaposed with IGH in B-cell malignancies with a t(2;14)(p13;q32). 49 By applying probes flanking the BCL11B/CTIP2 locus in the ATLL case with t(14;14)(q11;q32) studied here, a signal pattern indicating involvement of the BCL11B/CTIP2 locus was detected. This finding might suggest BCL11B/CTIP2 to be a candidate oncogene involved in the pathogenesis of ATLL, although further studies are required.
In order to expand the diagnostic power of the novel interphase FISH assays, we have established MI-FISH assays allowing the simultaneous detection of TCRA/D and TCRB translocations. In one out of five cases studied with the multicolor assays, breaks affecting both TCRA/D and TCRB were detected. This finding highlights the importance of screening methods whose application is not biased by cytogenetic information. Thus, translocations hidden in either highly rearranged or apparently normal chromosomes can be detected. Moreover, with the development of an M-FICTION assay, the sensitivity of this screening can be even significantly increased allowing the application of the interphase cytogenetic assays for the detection of minimal residual disease and in cases with low levels of tissue infiltration.
Conclusions
The FISH and FICTION assays reported in the present study allow the detection of known or unknown, cytogenetically visible or cryptic chromosomal abnormalities affecting any of the TCR loci. Thus, we provide new reliable tools for the rapid and sensitive detection of TCR-associated chromosomal aberrations in T-cell neoplasias, constituting an aid for the diagnosis Detection of TCR breakpoints by molecular cytogenetics S Gesk et al and research of these genetically poorly characterized malignant disorders.
